Constipation Management in Cerebral Palsy

First-Line Treatment Approach

The American Gastroenterological Association recommends polyethylene glycol (PEG) as the initial pharmacological treatment for chronic constipation management with strong evidence (moderate certainty) 1, 3
PEG can be combined with fiber supplementation for mild constipation, though adequate hydration must be ensured 1
Response to PEG has demonstrated durability over 6 months 1
Common side effects of PEG include abdominal distension, loose stool, flatulence, and nausea, but these are generally well-tolerated 1
PEG does not interact with antiepileptic medications, making it particularly suitable for patients with seizure disorders 1

Bisacodyl (10-15 mg, 2-3 times daily) or sodium picosulfate should be used for short-term management or rescue therapy with a goal of one non-forced bowel movement every 1-2 days 1, 2, 4
Short-term use is defined as daily use for 4 weeks or less, though longer-term use is probably appropriate 1, 2
Senna is an effective alternative stimulant laxative with conditional recommendation (low certainty evidence) 2, 5
Start at lower doses and increase as tolerated to minimize abdominal cramping 1, 2

The American Gastroenterological Association recommends avoiding magnesium oxide if there is any degree of renal insufficiency 1, 2, 6
Lactulose can be used safely if renal concerns exist, though it should be reserved for patients who fail or are intolerant to over-the-counter therapies 2, 6
Bloating and flatulence are dose-dependent common side effects of lactulose that may limit use 2, 6

Linaclotide, plecanatide, or prucalopride are recommended for patients not responding to first-line treatments (strong recommendation, moderate certainty) 3, 5
Lubiprostone is conditionally recommended as an alternative (conditional recommendation, low certainty) 2, 3, 5
Nausea risk is dose-dependent and lower when lubiprostone is taken with food and water 2, 5

Anticholinergic antiepileptic medications can worsen constipation 4
Probiotics with prebiotic fiber may provide additional benefit based on evidence from similar neurogenic constipation patterns 7
Fermented milk containing probiotics and prebiotic fiber improved bowel movement frequency and stool consistency 7

Never use magnesium oxide without confirming normal renal function in cerebral palsy patients who may have reduced mobility and hydration 1, 2, 6
Do not use methylnaltrexone or other opioid antagonists unless the patient is specifically on chronic opioid therapy 4
Avoid assuming fiber alone will be sufficient in neurogenic constipation; pharmacological agents are typically necessary 1, 7
Monitor for drug interactions between laxatives and antiepileptic medications, though PEG and bisacodyl have minimal interaction potential 1, 2